Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Long-Term Investments (2022 - 2023)

Updated

Impact Biomedical (IBO) recorded Long-Term Investments of $782,000 in Q2 2023.

Analysis

Impact Biomedical (IBO) Long-Term Investments (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,142.35 Bn 1,110.94 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 635.52 Bn 555.38 Bn 17.30 Bn -
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 266.00 Mn
4 Merck 356.35 Bn 310.72 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 300.53 Bn 264.52 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn 297.00 Mn
7 Amgen 238.00 Bn 193.40 Bn 7.24 Bn -
8 Gilead Sciences 194.35 Bn 168.55 Bn 6.22 Bn -
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 1.56 Bn
10 Impact Biomedical 397.86 Mn 397.82 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 782,000.00
Dec 31, 2022 782,000.00
API Access

Impact Biomedical Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=IBO&period=max&api_key=YOUR_API_KEY